
Abstract The voltage-gated sodium (Na V ) channel subtype Na V 1.7 plays a critical role in pain signaling, making it an important drug target. Here we studied the molecular interactions between μ-conotoxin KIIIA (KIIIA) and the human Na V 1.7 channel (hNa V 1.7). We developed a structural model of hNa V 1.7 using Rosetta computational modeling and performed in silico docking of KIIIA using RosettaDock to predict residues forming specific pairwise contacts between KIIIA and hNa V 1.7. We experimentally validated these contacts using mutant cycle analysis. Comparison between our KIIIA-hNa V 1.7 model and the cryo-EM structure of KIIIA-hNa V 1.2 revealed key similarities and differences between Na V channel subtypes with potential implications for the molecular mechanism of toxin block. The accuracy of our integrative approach, combining structural data with computational modeling, experimental validation, and molecular dynamics simulations, suggests that Rosetta structural predictions will be useful for rational design of novel biologics targeting specific Na V channels.
570, 1.1 Normal biological development and functioning, 610, voltage-gated sodium (NaV) channels, Bioengineering, RM1-950, conotoxins, protein-protein interaction, 5.1 Pharmaceuticals (hrcs-rac), Rosetta software, 32 Biomedical and Clinical Sciences (for-2020), protein-protein interaction (PPI), 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 1.1 Normal biological development and functioning (hrcs-rac), Pharmacology, Networking and Information Technology R&D (NITRD) (rcdc), Biomedical and Clinical Sciences, 1115 Pharmacology and Pharmaceutical Sciences (for), Pain Research, Bioengineering (rcdc), Pain Research (rcdc), Pharmacology and Pharmaceutical Sciences, Networking and Information Technology R&D (NITRD), 5.1 Pharmaceuticals, NaV1.7 channel, voltage-gated sodium (Na-V) channels, Na(V)1.7 channel, Therapeutics. Pharmacology, 3214 Pharmacology and pharmaceutical sciences (for-2020)
570, 1.1 Normal biological development and functioning, 610, voltage-gated sodium (NaV) channels, Bioengineering, RM1-950, conotoxins, protein-protein interaction, 5.1 Pharmaceuticals (hrcs-rac), Rosetta software, 32 Biomedical and Clinical Sciences (for-2020), protein-protein interaction (PPI), 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 1.1 Normal biological development and functioning (hrcs-rac), Pharmacology, Networking and Information Technology R&D (NITRD) (rcdc), Biomedical and Clinical Sciences, 1115 Pharmacology and Pharmaceutical Sciences (for), Pain Research, Bioengineering (rcdc), Pain Research (rcdc), Pharmacology and Pharmaceutical Sciences, Networking and Information Technology R&D (NITRD), 5.1 Pharmaceuticals, NaV1.7 channel, voltage-gated sodium (Na-V) channels, Na(V)1.7 channel, Therapeutics. Pharmacology, 3214 Pharmacology and pharmaceutical sciences (for-2020)
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
